Clinical Trial Update: A Trial of Bardoxolone Methyl in Patients With CKD at Risk of Rapid Progression (MERLIN) [Phase 2]

View source ↗

Summary

This document reports the completion of the MERLIN Phase 2 trial evaluating bardoxolone methyl in patients with chronic kidney disease at risk of rapid progress…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Bardoxolone Methyl (bardoxolone methyl)

Snippet

Sponsor: Biogen | Conditions: Chronic Kidney Diseases | Phase 2 | Status: COMPLETED | Results posted: 2022-12-01